WeVote
Log In

Bill

Bill

HR 7407

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

119th Congress Introduced by Frank Pallone

HR 7407 prohibits tianeptine and similar dangerous substances currently sold as unregulated supplements to prevent addiction and public health risks.

Introduced in House
1
WeVote Research Nonpartisan
Bill Summary · HR 7407

Legislative bill overview

HR 7407 seeks to prohibit the sale and distribution of tianeptine and other potentially dangerous products in the United States. Tianeptine is a drug marketed as a dietary supplement or nootropic (cognitive enhancer) but has opioid-like effects and carries risks of dependence and abuse. The bill would classify these substances as controlled or prohibited substances under federal law.

Why is this important

Tianeptine has gained popularity as an unregulated supplement despite evidence of addiction potential and withdrawal symptoms similar to opioid dependence. The growing market for tianeptine products—often sold as "gas station drugs" under brand names like Za Za Red or Tianna—has led to increasing emergency room visits and addiction cases, particularly among young adults. Federal prohibition could prevent widespread misuse while addressing a gap in current regulatory oversight.

Potential points of contention

  • Supplement industry push-back: Dietary supplement manufacturers may argue the bill overreaches into the supplement space and could set precedent for restricting other botanically-derived compounds
  • Medical application concerns: Tianeptine has legitimate use as an antidepressant in some countries; restricting it entirely may eliminate potential therapeutic pathways currently under research
  • Enforcement challenges: Defining the scope of "other dangerous products" remains vague and could affect unrelated industries or create definitional disputes during implementation

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.